$MNKD news
The latest MNKD stock news: headlines, filings, AI summaries and sentiment for $MNKD, updated around the clock.
- MannKind Reports Q3 2026 Revenue Growth Driven by Furoscix and scPharma Acquisition
- MannKind Projects $1 Billion in Revenue from United Therapeutics Deal and Targets Q4 Profitability
- MANNKIND CORP - 10-Q Filing
- MANNKIND CORP - 8-K Filing
- MannKind Collaborates with Rose Pharma on Inhaled Weight Loss Drug Amid Expanding Financial Challenges
- FDA Approves Mannkind's At-Home Treatment for Heart Failure and Kidney Disease
- MANNKIND CORP - 8-K Filing
- MannKind Executive Disposes of Shares Due to Tax Obligations from Restricted Stock Vesting
- MannKind Director Sells Shares Amid Royalties Revenue Concerns
- Insider Sale at MannKind Corporation Amid Tyvaso Royalties of $32.7 Million
- MannKind Insider Sells Shares to Cover Tax Liabilities
- MannKind Director Sells Shares Worth ~$313K Amid Royalties Revenue Concerns
- MannKind Executive Disposes of Shares Due to Tax Obligations from Vesting RSUs
- Insider Sale at MannKind Corporation Involves $500K Worth of Shares
- MannKind Insider Sells Shares to Cover Tax Liabilities
- MannKind CEO Sells 363,200 Shares to Cover Tax Liabilities
- MannKind Corporation (MNKD) Rises 20% Following FDA Approval of Afrezza for Pediatric Use
- MANNKIND CORP - 8-K Filing
- MANNKIND CORP - 8-K Filing
- MANNKIND CORP - 8-K Filing
- MannKind Corp Reports Q1 2026 Total Revenues of $90.2 Million
- MannKind Reports Q1 2026 Earnings with Revenue Growth and Key Product Updates